Issue |
E3S Web Conf.
Volume 363, 2022
XV International Scientific Conference on Precision Agriculture and Agricultural Machinery Industry “State and Prospects for the Development of Agribusiness - INTERAGROMASH 2022”
|
|
---|---|---|
Article Number | 03064 | |
Number of page(s) | 10 | |
Section | Precision Agriculture. Yield Monitoring and Estimation | |
DOI | https://doi.org/10.1051/e3sconf/202236303064 | |
Published online | 14 December 2022 |
The study of the Profort probiotic use in the specific prevention of salmonellosis in calves
All-Russian Research Veterinary Institute of Pathology, Pharmacology and Therapy, Lomonosova street, 114B, Voronezh, 394087, Russia
* Corresponding author: manol65@mail.ru
In order to increase the post-vaccination immune response during vaccination of calves against salmonellosis, a test was carried out with an inactivated emulsified vaccine against the background of the use of the probiotic Profort. The studies were carried out on the basis of a large livestock farm in the Voronezh region, unfavorable for salmonellosis of calves. Epizootological, clinical, immunological, hematological, molecular genetic research methods were used in the work. Studies have shown that vaccination of calves against salmonellosis against the background of the use of the probiotic preparation Profort with an inactivated emulsified vaccine contributed to the development of intense cellular immunity – an increase in the total number of lymphocytes and T-cells by 7.0%, B-cells – by 2.8%%, phagocytic activity of neutrophils - by 5.9%, phagocytic number – by 7.2%, phagocytic index – by 7.0%, as well as humoral immunity factors – BaS by 3.0%, LaS – by 3.0%%, CaS – by 1.7%, O- and H-agglutinins to salmonella antigen – 1.5 and 2 times, respectively. The use of Profort increases the protective properties of the vaccine against salmonellosis, helps to reduce the incidence by 13.3%, and increase the safety of young animals by 26.6%. Therefore, to optimize the use of Profort probiotic, it is necessary to take into account its immunomodulatory effect.
© The Authors, published by EDP Sciences, 2022
This is an Open Access article distributed under the terms of the Creative Commons Attribution License 4.0, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.